[HTML][HTML] Apoptosis in cancer: from pathogenesis to treatment
RSY Wong - Journal of experimental & clinical cancer research, 2011 - Springer
Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and
pathological conditions. It is also one of the most studied topics among cell biologists. An …
pathological conditions. It is also one of the most studied topics among cell biologists. An …
Esophageal motility disorders on high‐resolution manometry: Chicago classification version 4.0©
…, R Tutuian, MF Vela, RK Wong… - …, 2021 - Wiley Online Library
Chicago Classification v4.0 (CCv4.0) is the updated classification scheme for esophageal
motility disorders using metrics from high‐resolution manometry (HRM). Fifty‐two diverse …
motility disorders using metrics from high‐resolution manometry (HRM). Fifty‐two diverse …
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
…, M Scully, Y Tomiyama, RS Wong… - Blood …, 2019 - ashpublications.org
Over the last decade, there have been numerous developments and changes in treatment
practices for the management of patients with immune thrombocytopenia (ITP). This article is …
practices for the management of patients with immune thrombocytopenia (ITP). This article is …
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
… Statistical analysis was performed in R by using the survival package. Graph-Pad Prism …
of Pathology and the Marie-Josée and Henry R. Kravis Center for Molecular Oncology. We …
of Pathology and the Marie-Josée and Henry R. Kravis Center for Molecular Oncology. We …
[HTML][HTML] Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults
…, ML Puckett, HA Hildebrandt, RK Wong… - … England Journal of …, 2003 - Mass Medical Soc
Background We evaluated the performance characteristics of computed tomographic (CT)
virtual colonoscopy for the detection of colorectal neoplasia in an average-risk screening …
virtual colonoscopy for the detection of colorectal neoplasia in an average-risk screening …
[HTML][HTML] Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study
…, RK Wong, A Lopez-Colombo, V Costa, R Dickman… - Gastroenterology, 2021 - Elsevier
Background & Aims Although functional gastrointestinal disorders (FGIDs), now called
disorders of gut-brain interaction, have major economic effects on health care systems and …
disorders of gut-brain interaction, have major economic effects on health care systems and …
[HTML][HTML] Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
Background The role of adjuvant chemotherapy in stage II colon cancer continues to be
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
debated. The presence of circulating tumor DNA (ctDNA) after surgery predicts very poor …
[PDF][PDF] Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study
…, A Figer, R Wong… - Journal of …, 2008 - mauriciolema.webhost4life.com
Purpose To evaluate the efficacy and safety of bevacizumab when added to first-line
oxaliplatin-based chemotherapy (either capecitabine plus oxaliplatin [XELOX] or fluorouracil/folinic …
oxaliplatin-based chemotherapy (either capecitabine plus oxaliplatin [XELOX] or fluorouracil/folinic …
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
RJ Wong, M Aguilar, R Cheung, RB Perumpail… - Gastroenterology, 2015 - Elsevier
Background & Aims Nonalcoholic steatohepatitis (NASH) has been predicted to become the
leading indication for liver transplantation (LT) in the United States. However, few studies …
leading indication for liver transplantation (LT) in the United States. However, few studies …
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a …
…, B Osterwalder, AO Wong, R Wong - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: To compare the response rate, efficacy parameters, and toxicity profile of oral
capecitabine with bolus intravenous (IV) fluorouracil plus leucovorin (5-FU/LV) as first-line …
capecitabine with bolus intravenous (IV) fluorouracil plus leucovorin (5-FU/LV) as first-line …